Is Mink Therapeutics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Mink Therapeutics Inc (INKT) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Mink Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mink Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Mink Therapeutics Inc?

Muslim investors may consider investing in Mink Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Mink Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Mink Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Mink Therapeutics Inc updated?

The Shariah compliance status of Mink Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Mink Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Mink Therapeutics Inc?

You can check the latest Shariah compliance status of Mink Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

INKT Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 03, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Mink Therapeutics Inc (INKT)

Based on 8 analysts giving stock ratings to Mink Therapeutics Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Mink Therapeutics Inc. Stock Analysis INKT

United States Health Care Micro Cap Report: 2025 Annual

The company is headquartered in New York City, New York and currently employs 15 full-time employees. The company went IPO on 2021-10-15.

Key Statistics of Mink Therapeutics Inc (INKT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$10.18$11.49

Today's Open

$11.09

Volume

36.57K

P/E Ratio (TTM)

52 Week Range

$6.65$76.00

Market Cap

57.31M

Avg. Volume

42.90K

Dividend Yield

Financial Metrics & Statements of Mink Therapeutics Inc (INKT)

FAQ's for Mink Therapeutics Inc (INKT)

According to Musaffa’s Shariah screening methodology, Mink Therapeutics Inc (INKT) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.